We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INMB icon
3976
INmune Bio
INMB
$60.2M
$13K ﹤0.01%
2,037
+534
+36% +$4.3K
IPAY icon
3977
Amplify Mobile Payments ETF
IPAY
$188M
$13K ﹤0.01%
314
IPI icon
3978
Intrepid Potash
IPI
$493M
$13K ﹤0.01%
485
-4,369
-90% -$133K
IRMD icon
3979
iRadimed
IRMD
$1.11B
$13K ﹤0.01%
323
+17
+6% +$618
KRUS icon
3980
Kura Sushi USA
KRUS
$643M
$13K ﹤0.01%
201
-2,446
-92% -$147K
LIND icon
3981
Lindblad Expeditions
LIND
$2.2B
$13K ﹤0.01%
1,367
-8,331
-86% -$83.8K
LXRX icon
3982
Lexicon Pharmaceuticals
LXRX
$1.03B
$13K ﹤0.01%
5,611
-713
-11% -$1.63K
MCS icon
3983
Marcus Corp
MCS
$925M
$13K ﹤0.01%
835
-12,549
-94% -$193K
MCW
3984
DELISTED
Mister Car Wash
MCW
$13K ﹤0.01%
1,505
+330
+28% +$3.09K
MITK icon
3985
Mitek Systems
MITK
$877M
$13K ﹤0.01%
1,347
-13,723
-91% -$132K
MOVE icon
3986
Corvex Inc
MOVE
$324M
$13K ﹤0.01%
95
+53
+126% +$8.41K
MPX
3987
DELISTED
Marine Products Corp
MPX
$13K ﹤0.01%
955
+185
+24% +$2.41K
NAUT icon
3988
Nautilus Biotechnolgy
NAUT
$114M
$13K ﹤0.01%
4,733
-1,079
-19% -$2.26K
NKSH icon
3989
National Bankshares
NKSH
$270M
$13K ﹤0.01%
410
+395
+2,633% +$15.7K
NODK icon
3990
NI Holdings
NODK
$312M
$13K ﹤0.01%
998
+239
+31% +$3.2K
OCUL icon
3991
Ocular Therapeutix
OCUL
$2.2B
$13K ﹤0.01%
2,526
-14,159
-85% -$67.2K
OPI
3992
DELISTED
Office Properties Income Trust
OPI
$13K ﹤0.01%
1,033
+596
+136% +$9.15K
OPTN
3993
DELISTED
OptiNose
OPTN
$13K ﹤0.01%
436
+236
+118% +$6.28K
ORRF icon
3994
Orrstown Financial Services
ORRF
$852M
$13K ﹤0.01%
695
+8
+1% +$182
PPTA
3995
Perpetua Resources
PPTA
$3.16B
$13K ﹤0.01%
2,976
+25
+0.8% +$87
PRTH icon
3996
Priority Technology Holdings
PRTH
$453M
$13K ﹤0.01%
3,699
+1,987
+116% +$8.48K
PWP icon
3997
Perella Weinberg Partners
PWP
$1.29B
$13K ﹤0.01%
1,430
+1,073
+301% +$10.7K
RDW icon
3998
Redwire
RDW
$3.39B
$13K ﹤0.01%
4,352
-878
-17% -$2.59K
REKR icon
3999
Rekor Systems
REKR
$98.2M
$13K ﹤0.01%
10,132
-20,161
-67% -$32.1K
RFIL icon
4000
RF Industries
RFIL
$148M
$13K ﹤0.01%
3,015
+1,325
+78% +$6.65K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.